4119.TW · SCI
Taiwan · RS rating 71 · As of 2026-10-08
| Price | 54.40 TWD |
|---|---|
| 1-day change | +1.5% |
| RS rating (overall / 1M / 3M / 12M) | 71 / 45 / 89 / 43 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 38 / 46 / 37 |
| Industry group (rank) | Biotechnology & Medical Care (50) |
| EPS growth Q/Q | -164.7% |
| Sales growth Q/Q | -27.4% |
| Distance from 52-week high | +9.6% |
| Market cap (USD) | $208.1M |